Makers of some of the most lucrative pharmaceutical products ever produced are headed for a slump in revenues as deliveries of Covid-19 vaccines almost halve next year, according to new forecasts.
根據最新預測，由于明年新冠疫苗的交付量幾乎減半，有史以來最賺錢的一些醫藥產品制造商將面臨收入下滑的局面。
您已閱讀5%（248字），剩余95%（4565字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。